Lannett Co., Inc.

( )
LCI PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Major
ABBVAbbVie, Inc. -0.96%92.131.9%$1145.22m
JNJJohnson & Johnson -0.87%144.440.7%$1085.68m
BMYBristol-Myers Squibb Co. -0.57%60.791.0%$940.95m
PFEPfizer Inc. 0.64%37.500.9%$816.71m
MRKMerck & Co., Inc. -0.22%76.380.7%$776.51m
LLYEli Lilly & Co. -0.69%151.231.1%$447.35m
AZNAstraZeneca Plc -0.11%55.221.2%$249.77m
NVSNovartis AG -0.09%84.910.2%$158.95m
GSKGlaxoSmithKline Plc -0.37%40.880.2%$141.36m
BHCBausch Health Cos., Inc. -2.26%17.770.0%$113.04m
SNYSanofi -0.30%47.300.2%$86.66m
NVONovo Nordisk A/S 0.05%64.850.1%$84.91m
RGENRepligen Corp. -0.57%139.517.1%$72.80m
ARCTArcturus Therapeutics Holdings, Inc. 7.71%58.270.0%$57.13m
BHVNBiohaven Pharmaceutical Holding Co. Ltd. 11.80%58.370.0%$43.19m

Company Profile

Lannett Co., Inc. engages in the development, manufacture, marketing, and distribution of generic pharmaceutical products. It offers products in different forms including capsules, tablets, liquids, powders, and sprays. The company was founded in 1942 and is headquartered in Philadelphia, PA.